SCHEMBL18757668

SCHEMBL18757668

NC(=O)C1=C(N)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14081363 0.92 KDM4E (0.38) —
SCHEMBL8197869 0.92 KDM4E (0.38) —
SCHEMBL12475847 0.83 ALDH1A1 (0.37) —
SCHEMBL2209103 0.79 — —
SCHEMBL4447758 0.77 ALDH1A1 (0.37) —
SCHEMBL10123519 0.74 TSHR (0.32) —
SCHEMBL6885953 0.74 — —
SCHEMBL4023693 0.74 TSHR (0.32) —
SCHEMBL10017853 0.74 PARP1 (0.46) —
SCHEMBL13544696 0.72 KDM4E (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017066428-A1 BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE, INC. (US) 2017-04-20 — — WO disclosed
Send feedback